The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of definitive chemoradiation with gemcitabine and the WEE1 inhibitor AZD1775 in unresectable pancreatic cancer.
 
Kyle Clifford Cuneo
Research Funding - BTG; Varian Medical Systems
 
Meredith Morgan
No Relationships to Disclose
 
Matthew J Schipper
No Relationships to Disclose
 
Jonathan Maybaum
No Relationships to Disclose
 
Mahmoud Al-Hawary
No Relationships to Disclose
 
Diane M. Simeone
Consulting or Advisory Role - Celgene
Research Funding - Abbvie
Patents, Royalties, Other Intellectual Property - small royalties for my patent on pancreatic cancer stem cells also I receive an annual royalty for a textbook I edited Greenfields Textbook of Surgery
Travel, Accommodations, Expenses - Celgene
 
Vaibhav Sahai
Honoraria - Celgene; Merrimack
Consulting or Advisory Role - Celgene
 
Mark Zalupski
No Relationships to Disclose
 
Theodore Steven Lawrence
No Relationships to Disclose